Clinical Trials · NCT06820476
A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants After 10 Days of Oral Dosing
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 29
- Start date
- Feb 2025
- Locations
- 2 sites, China
- Primary endpoint
- Number of treatment emergent adverse events (TEAEs)